Antibiotics Alter Methotrexate Metabolism and Excretion von Zaharko, Daniel S., Bruckner, Howard, Oliverio, Vincent T.

Volltext

Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells von COVEY, J. M, D'INCALCI, M, TILCHEN, E. J, ZAHARKO, D. S, KOHN, K. W

Volltext

Treatment of solid L1210 murine tumors with local hyperthermia and temperature-sensitive liposomes containing methotrexate von Weinstein, J N, Magin, R L, Cysyk, R L, Zaharko, D S

Volltext

DNA alkali-labile sites induced by incorporation of 5-aza-2'-deoxycytidine into DNA of mouse leukemia L1210 cells von DINCALCI, M, COVEY, J. M, ZAHARKO, D. S, KOHN, K. W

Volltext

The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides von Pinedo, H M, Zaharko, D S, Bull, J M, Chabner, B A

Volltext

Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro von Erickson, L C, Ramonas, L M, Zaharko, D S, Kohn, K W

Volltext

Antitumor activity of monomeric and polymeric cyclophosphamide derivatives compared with in vitro hydrolysis von Hirano, T, Ringsdorf, H, Zaharko, D S

Volltext

Pharmacokinetic studies during phase I trials of high-dose thymidine infusions von Zaharko, D S, Bolten, B J, Chiuten, D, Wiernik, P H

Volltext

The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion von Pinedo, H M, Zaharko, D S, Bull, J, Chabner, B A

Volltext

Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide von Ramonas, L M, Erickson, L C, Ringsdorf, H, Zaharko, D S

Volltext

Clinical phase I-II and pharmacokinetic study of high-dose thymidine given by continuous intravenous infusion von Chiuten, D F, Wiernik, P H, Zaharko, D S, Edwards, L

Volltext

Relative biochemical aspects of low and high doses of methotrexate in mice von Zaharko, D S, Fung, W P, Yang, K H

Volltext

ANTIBIOTICS ALTER METHOTREXATE METABOLISM AND EXCRETION von ZAHARKO, DANIEL S, BRUCKNER, HOWARD, OLIVERIO, VINCENT T

Volltext

Chloroquinoxaline sulfonamide : a sulfanilamide antitumor agent entering clinical trials von FISHERMAN, J. S, OSBORN, B. L, CHUN, H. G, PLOWMAN, J, SMITH, A. C, CHRISTIAN, M. C, ZAHARKO, D. S, SHOEMAKER, R. H

Volltext

Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light von CREEKMORE, S. P, ZAHARKO, D. S

Volltext

Flavone acetic acid (LM 975, NSC 347512): a novel antitumor agent von O'DWYER, P. J, SHOEMAKER, D, LEYLAND-JONES, ZAHARKO, D. S, GRIESHABER, C, PLOWMAN, J, CORBETT, T, VALERIOTE, F, KING, S. A, CRADOCK, J, HOTH, D. F

Volltext

Cyclopentenyl cytosine : interspecies predictions based on rodent plasma and urine kinetics von ZAHARKO, D. S, KELLEY, J. A, TOMASZEWSKI, J. E, HEGEDUS, L, HARTMAN, N. R

Volltext

Immunological Concepts and the Combination of Cyclophosphamide with 5-Aza-2′-Deoxycytidine on L1210 in Vivo von Zaharko, Daniel S.

Volltext

Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients? von CASSIDY, J, KERR, D. J, SETANOIANS, A, ZAHARKO, D. S, KAYE, S. B

Volltext

Physiological pharmacokinetics: An in vivo approach to membrane transport von Lutz, Robert J., Dedrick, Robert L., Zaharko, Daniel S.

Volltext